Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Comorbidity Differentiation and Risk Stratification in the Elderly Patient with Polypharmacy: A Prospective Primary Care Registry on Oral Anticoagulation Therapy
Author(s): S van Vugt , G Aarts , E Lamfers , et al Added: 3 years ago
Objectives: Although polypharmacy is an accepted proxy for multi-morbidity, there has been limited attention for risk stratification among polypharmacy patients, especially in the elderly. We used the number of drug classes prescribed to determine the extent of co-morbidity and the risk of adverse outcome. Methods: Prospective study among elderly patients (≥75 years) with polypharmacy (≥5 drugs)… View more

Prevention & Chronic Conditions
Amina Rakisheva
Job title: Consultant in Cardiology Department
Dr Amina Rakisheva is a Heart Failure specialist, Consultant in Cardiology Department, Scientific Research Institute of Cardiology and Internal Medicine, Almaty, Kazakhstan. Dr Rakisheva is elected Board Member of the Heart Failure Association of the ESC, ESC Young Community Board Member in 2020 and she was elected Member of the ESC Clinical Practice Guidelines of the ESC. Since 2018 to the… View more
Evaluation of the Effect of Heart Failure Reversal Therapy on Exercise Capacity in Patients with Chronic Heart Failure and the Association with Co-morbidities
Author(s): R Sane Added: 3 years ago
Aims: New treatment modalities are needed to improve the aerobic capacity of patients with chronic heart failure (CHF), considering the increasing disease prevalence. This study was done to evaluate the effect of heart failure reversal therapy (HFRT) on exercise indices, viz.VO2 max and metabolic equivalents (METs). Methodology: This retrospective study screened data of 147 patients who visited… View more

Heart Failure
Time to Integrate Sex in Management of Aortic Valve Stenosis
Author(s): Eva Gerdts , Helga Midtbø Added: 1 year ago

Demographic

Prevention & Chronic Conditions
Author(s): Thomas Kahan Added: 3 years ago
High blood pressure is the major risk factor for disease and premature death worldwide.1 The associations between blood pressure and fatal coronary artery disease and fatal stroke have been well demonstrated.2 Also, associations between blood pressure and morbidity and mortality on specific cardiovascular disease conditions in different age groups, and results concerning the lifetime risk for… View more

Standards & Guidelines

Prevention & Chronic Conditions
TCT 23: IFR SWEDEHEART
Author(s): Matthias Gotberg Added: 5 months ago
TCT 23 - We are joined by Dr Matthias Götberg (Lund University, SE) to discuss recent findings from a study of the SWEDEHEART Registry, where the long-term outcomes of iFR vs FFR guided coronary revascularization were compared. Results suggest that in a national registry analysis of 42887 patients investigated with iFR or FFR with 5-year follow-up, similar outcomes were observed in MACE, all… View more

Prevention & Chronic Conditions

Intervention
ACC.24: The STEP HFpEF DM Trial
Author(s): Mikhail Kosiborod Added: 1 week ago
ACC.24 — We are joined onsite by Dr Mikhail Kosiborod (Saint Luke’s Mid America Heart Institute, US) to discuss the findings from the STEP HFpEF DM Trial (NCT04916470).The STEP HFpEF DM study aimed to investigate the effect of taking semaglutide 2.4mg once weekly in patients with heart failure with preserved ejection fraction (HFpEF) and diabetes mellitus type 2. The study looked at the impact of… View more

Heart Failure

Prevention & Chronic Conditions
Author(s): Alessandro Marinelli , Mario Luzi , Alessandro Capucci Added: 3 years ago
Several randomised controlled trials (RCTs) have proven the efficacy of the implantable cardioverter-defibrillator (ICD) in preventing sudden cardiac death (SCD) in patients with advanced systolic heart failure (HF) and reduced left ventricular ejection fraction (LVEF).1–3 ICD therapy proved to be efficacious also in other conditions at high risk for arrhythmic death such as familial SCD… View more

Heart Failure

Electrophysiology & Arrhythmia
Ablation as First-line Therapy for Atrial Fibrillation.
Author(s): Jason G Andrade Added: 8 months ago

Electrophysiology & Arrhythmia
Gaps in Modern Heart Failure and Chronic Kidney Disease Research
Author(s): Simran Singh Parmar , Vasantha Muthuppalaniappan , Debasish Banerjee Added: 8 months ago

Heart Failure